Context-dependent switch in chemo/mechanotransduction via multilevel crosstalk among cytoskeleton-regulated MRTF and TAZ and TGFβ-regulated Smad3

Nature Communications

Volumn 7, Issue , 2016, Pages

  Speight, Pam ^a   Kofler, Michael ^a   Szászi, Katalin ^a,b   Kapus, András ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MYOCARDIN RELATED TRANSCRIPTION FACTOR; SMAD3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TAZ; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ACTIN;

CHEMICAL CUE; CHEMORECEPTION; CYTOPLASM; GENE EXPRESSION; GENETIC ANALYSIS; MECHANORECEPTION; MOBILITY; MUSCLE; PHYSIOLOGICAL RESPONSE; PROTEIN;

ARTICLE; CYTOSKELETON; MECHANOTRANSDUCTION; MOLECULAR INTERACTION; MYOFIBROBLAST; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; REGULATORY MECHANISM; ANIMAL; LLC PK1 CELL LINE; METABOLISM; PIG; RECEPTOR CROSS-TALK;

ACTINS; ANIMALS; LLC-PK1 CELLS; MECHANOTRANSDUCTION, CELLULAR; RECEPTOR CROSS-TALK; SMAD3 PROTEIN; SWINE; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84969974038     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11642     Document Type: Article

References (68)

1. Halder, G., Dupont, S. & Piccolo, S. Transduction of mechanical and cytoskeletal cues by YAP and TAZ. Nat. Rev. Mol. Cell Biol. 13, 591-600 (2012).
2. Janmey, P. A., Wells, R. G., Assoian, R. K. & McCulloch, C. A. From tissue mechanics to transcription factors. Differentiation 86, 112-120 (2013).
3. Mammoto, T., Mammoto, A. & Ingber, D. E. Mechanobiology and developmental control. Annu. Rev. Cell Dev. Biol. 29, 27-61 (2013).
4. Guettler, S., Vartiainen, M. K., Miralles, F., Larijani, B. & Treisman, R. RPEL motifs link the serum response factor cofactor MAL but not myocardin to Rho signaling via actin binding. Mol. Cell. Biol. 28, 732-742 (2008).
5. Marjoram, R. J., Lessey, E. C. & Burridge, K. Regulation of RhoA activity by adhesion molecules and mechanotransduction. Curr. Mol. Med. 14, 199-208 (2014).
6. Olson, E. N. & Nordheim, A. Linking actin dynamics and gene transcription to drive cellular motile functions. Nat. Rev. Mol. Cell Biol. 11, 353-365 (2010).
7. Rajakyla, E. K. & Vartiainen, M. K. Rho, nuclear actin, and actin-binding proteins in the regulation of transcription and gene expression. Small GTPases 5, e27539 (2014).
8. Posern, G. & Treisman, R. Actin' together: serum response factor, its cofactors and the link to signal transduction. Trends Cell Biol. 16, 588-596 (2006).
9. Piccolo, S., Dupont, S. & Cordenonsi, M. The biology of YAP/TAZ: hippo signaling and beyond. Physiol. Rev. 94, 1287-1312 (2014).
10. Low, B. C. et al. YAP/TAZ as mechanosensors and mechanotransducers in regulating organ size and tumor growth. FEBS Lett. 588, 2663-2670 (2014).
11. Dupont, S. et al. Role of YAP/TAZ in mechanotransduction. Nature 474, 179-183 (2011).
12. Gomez, E. W., Chen, Q. K., Gjorevski, N. & Nelson, C. M. Tissue geometry patterns epithelial-mesenchymal transition via intercellular mechanotransduction. J. Cell. Biochem. 110, 44-51 (2010).
13. Fan, L. et al. Cell contact-dependent regulation of epithelial-myofibroblast transition via the rho-rho kinase-phospho-myosin pathway. Mol. Biol. Cell 18, 1083-1097 (2007).
14. Varelas, X. et al. The Crumbs complex couples cell density sensing to Hippodependent control of the TGF-beta-SMAD pathway. Dev. Cell 19, 831-844 (2010).
15. Busche, S., Descot, A., Julien, S., Genth, H. & Posern, G. Epithelial cell-cell contacts regulate SRF-mediated transcription via Rac-actin-MAL signalling. J. Cell Sci. 121, 1025-1035 (2008).
16. Zhao, B. et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 21, 2747-2761 (2007).
17. Speight, P., Nakano, H., Kelley, T. J., Hinz, B. & Kapus, A. Differential topical susceptibility to TGFbeta in intact and injured regions of the epithelium: key role in myofibroblast transition. Mol. Biol. Cell 24, 3326-3336 (2013).
18. Miralles, F., Posern, G., Zaromytidou, A. I. & Treisman, R. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113, 329-342 (2003).
19. Sansores-Garcia, L. et al. Modulating F-actin organization induces organ growth by affecting the Hippo pathway. EMBO J. 30, 2325-2335 (2011).
20. Wada, K., Itoga, K., Okano, T., Yonemura, S. & Sasaki, H. Hippo pathway regulation by cell morphology and stress fibers. Development 138, 3907-3914 (2011).
21. Aragona, M. et al. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell 154, 1047-1059 (2013).
22. Vartiainen, M. K., Guettler, S., Larijani, B. & Treisman, R. Nuclear actin regulates dynamic subcellular localization and activity of the SRF cofactor MAL. Science 316, 1749-1752 (2007).
23. Miano, J. M., Long, X. & Fujiwara, K. Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am. J. Physiol. Cell Physiol. 292, C70-C81 (2007).
24. Esnault, C. et al. Rho-actin signaling to the MRTF coactivators dominates the immediate transcriptional response to serum in fibroblasts. Genes Dev. 28, 943-958 (2014).
25. Masszi, A. et al. Fate-determining mechanisms in epithelial-myofibroblast transition: major inhibitory role for Smad3. J. Cell Biol. 188, 383-399 (2010).
26. Rozycki, M. et al. Myocardin-related transcription factor regulates Nox4 protein expression: linking cytoskeletal organization to redox state. J. Biol. Chem. 291, 227-243 (2016).
27. Zhao, X. H. et al. Force activates smooth muscle alpha-actin promoter activity through the Rho signaling pathway. J. Cell Sci. 120, 1801-1809 (2007).
28. Small, E. M. et al. Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ. Res. 107, 294-304 (2010).
29. Scharenberg, M. A. et al. TGF-beta-induced differentiation into myofibroblasts involves specific regulation of two MKL1 isoforms. J. Cell Sci. 127, 1079-1091 (2014).
30. Crider, B. J., Risinger, Jr G. M., Haaksma, C. J., Howard, E. W. & Tomasek, J. J. Myocardin-related transcription factors A and B are key regulators of TGF-beta1-induced fibroblast to myofibroblast differentiation. J. Invest. Dermatol. 131, 2378-2385 (2011).
31. Moustakas, A. & Heldin, P. TGFbeta and matrix-regulated epithelial to mesenchymal transition. Biochim. Biophys. Acta 1840, 2621-2634 (2014).
32. Hinz, B. et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am. J. Pathol. 180, 1340-1355 (2012).
33. Sebe, A. et al. Rac, PAK and p38 regulate cell contact-dependent nuclear translocation of myocardin-related transcription factor. FEBS Lett. 582, 291-298 (2008).
34. Morita, T., Mayanagi, T. & Sobue, K. Dual roles of myocardin-related transcription factors in epithelial mesenchymal transition via slug induction and actin remodeling. J. Cell Biol. 179, 1027-1042 (2007).
35. Charbonney, E., Speight, P., Masszi, A., Nakano, H. & Kapus, A. β-catenin and Smad3 regulate the activity and stability of myocardin-related transcription factor during epithelial-myofibroblast transition. Mol. Biol. Cell 22, 4472-4485 (2011).
36. Varelas, X. et al. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat. Cell Biol. 10, 837-848 (2008).
37. Moroishi, T., Hansen, C. G. & Guan, K. L. The emerging roles of YAP and TAZ in cancer. Nat. Rev. Cancer 15, 73-79 (2015).
38. Lamar, J. M. et al. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain. Proc. Natl Acad. Sci. USA 109, E2441-E2450 (2012).
39. Plouffe, S. W., Hong, A. W. & Guan, K. L. Disease implications of the Hippo/YAP pathway. Trends Mol. Med. 21, 212-222 (2015).
40. Liu, F. et al. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 308, L344-L357 (2015).
41. Machado, M. V. et al. Accumulation of duct cells with activated YAP parallels fibrosis progression in nonalcoholic fatty liver disease. J. Hepatol. 63, 962-970 (2015).
42. Mannaerts, I. et al. The Hippo pathway effector YAP controls mouse hepatic stellate cell activation. J. Hepatol. 63, 679-688 (2015).
43. Szeto, S. G. YAP and TAZ are mechanoregulators of TGFβ-Smad signaling in renal fibrogenesis. J. Am. Soc. Nephrol. Mar 9. pii: ASN.2015050499. [Epub ahead of print] (2016).
44. Zhao, B., Tumaneng, K. & Guan, K. L. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat. Cell Biol. 13, 877-883 (2011).
45. Zhang, H. et al. TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. J. Biol. Chem. 284, 13355-13362 (2009).
46. Reddy, P., Deguchi, M., Cheng, Y. & Hsueh, A. J. Actin cytoskeleton regulates Hippo signaling. PloS One 8, e73763 (2013).
47. Chan, S. W. et al. WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ. Oncogene 30, 600-610 (2011).
48. Hayashi, K. & Morita, T. Differences in the nuclear export mechanism between myocardin and myocardin-related transcription factor A. J. Biol. Chem. 288, 5743-5755 (2013).
49. Lei, Q. Y. et al. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol. Cell. Biol. 28, 2426-2436 (2008).
50. Masszi, A. et al. Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. Am. J. Pathol. 165, 1955-1967 (2004).
51. Hiemer, S. E., Szymaniak, A. D. & Varelas, X. The transcriptional regulators TAZ and YAP direct transforming growth factor beta-induced tumorigenic phenotypes in breast cancer cells. J. Biol. Chem. 289, 13461-13474 (2014).
52. Xie, C. et al. Yap1 protein regulates vascular smooth muscle cell phenotypic switch by interaction with myocardin. J. Biol. Chem. 287, 14598-14605 (2012).
53. Yu, O. M., Miyamoto, S. & Brown, J. H. Myocardin-related transcription factor a and yes-associated protein exert dual control in G protein-coupled receptor- and RhoA-mediated transcriptional regulation and cell proliferation. Mol. Cell. Biol. 36, 39-49 (2015).
54. Liu, F., Wang, X., Hu, G., Wang, Y. & Zhou, J. The transcription factor TEAD1 represses smooth muscle-specific gene expression by abolishing myocardin function. J. Biol. Chem. 289, 3308-3316 (2014).
55. Wang, D. et al. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105, 851-862 (2001).
56. Mana-Capelli, S., Paramasivam, M., Dutta, S. & McCollum, D. Angiomotins link F-actin architecture to Hippo pathway signaling. Mol. Biol. Cell 25, 1676-1685 (2014).
57. Kanai, F. et al. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J. 19, 6778-6791 (2000).
58. Liu, C. Y. et al. MRTF/SRF dependent transcriptional regulation of TAZ in breast cancer cells. Oncotarget. doi:10.18632/oncotarget.7333 (2016).
59. Creemers, E. E., Sutherland, L. B., McAnally, J., Richardson, J. A. & Olson, E. N. Myocardin is a direct transcriptional target of Mef2, Tead and Foxo proteins during cardiovascular development. Development 133, 4245-4256 (2006).
60. Swartz, E. A., Johnson, A. D. & Owens, G. K. Two MCAT elements of the SM alpha-actin promoter function differentially in SM versus non-SM cells. Am. J. Physiol. 275, C608-C618 (1998).
61. Masszi, A. & Kapus, A. Smaddening complexity: the role of Smad3 in epithelial-myofibroblast transition. Cells Tissues Organs 193, 41-52 (2011).
62. Gan, Q., Yoshida, T., Li, J. & Owens, G. K. Smooth muscle cells and myofibroblasts use distinct transcriptional mechanisms for smooth muscle alpha-actin expression. Circ. Res. 101, 883-892 (2007).
63. Small, E. M. The actin-MRTF-SRF gene regulatory axis and myofibroblast differentiation. J. Cardiovasc. Transl. Res. 5, 794-804 (2012).
64. Sasazuki, T. et al. Identification of a novel transcriptional activator, BSAC, by a functional cloning to inhibit tumor necrosis factor-induced cell death. J. Biol. Chem. 277, 28853-28860 (2002).
65. Ly, D. L. et al. Hyperosmotic stress regulates the distribution and stability of myocardin-related transcription factor, a key modulator of the cytoskeleton. Am. J. Physiol. Cell Physiol. 304, C115-C127 (2013).
66. Couzens, A. L. et al. Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions. Sci. Signal. 6, rs15 (2013).
67. Abraham, D. J. et al. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J. Biol. Chem. 275, 15220-15225 (2000).
68. Rapsomaniki, M. A. et al. easy FRAP: an interactive, easy-to-use tool for qualitative and quantitative analysis of FRAP data. Bioinformatics 28, 1800-1801 (2012).